Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Lukas Amrell"'
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Tucatinib (TUC), a HER2-directed tyrosine kinase inhibitor, is the first targeted drug demonstrating intracranial efficacy and significantly prolonged survival in metastatic HER2-positive breast cancer (BC) patients with brain met
Externí odkaz:
https://doaj.org/article/9cf7e6b94efd4a4a95a977a74d3e3670
